NCI Renews Partnership with UNC to Seek New Cancer Drugs
October 6, 2016
The University of North Carolina at Chapel Hill will pursue treatments for specific cancer targets as a specialized member of the National Cancer Institute’s renewed Experimental Therapeutics, or NExT, program through a contract with Leidos Biomed and its Frederick National … Read more